THEIA development, and testing of artificial intelligence-based primary triage of diabetic retinopathy screening images in New Zealand – In Publication.
THEIA’s Performance Assessed using a cloud platform
Towards implementation of AI in New Zealand national diabetic screening program: Cloud-based, robust, and bespoke.
THEIA used OCTA for diagnosis of AMD
Quantification of optical coherence tomography angiography in age and age-related macular degeneration using vessel density analysis.